Leadership

Leadership

We are proud of our reputation for attracting and developing some of the brightest leaders in the healthcare technology industry. Our leadership team is laser-focused on realizing our vision: The Rothman Index will be used for every patient in every care setting to inform clinical decisions and optimize healthcare performance.

Joseph Beals

Joseph Beals, PhD

Chief Executive Officer
Joseph Beals

PeraHealth exemplifies the translation of data-driven technology solutions into meaningful clinical outcomes.

Joseph Beals, PhD

Chief Executive Officer

Joe is an accomplished executive with broad experience leading the commercialization of emerging technologies.

As one of PeraHealth’s first employees, Joe is a foundational member of the company. Over his 10+ years at PeraHealth he has driven growth and innovation across all aspects of the organization.

Prior to joining PeraHealth, he worked at the Centre for Advanced Photonics and Electronics and at the Fraunhofer Center for Manufacturing Innovation.

Joe has expertise in the real-world applications of technology in diverse fields and has published on medical predictive analytics, quantum electrodynamics, opto-electronics, neural engineering, and fluid mechanics, and holds a patent in high-bandwidth optical data routing. His work in healthcare informatics has received accolades and awards from the American Medical Informatics Association and the Society of Critical Care Medicine.

He earned an ScB from Brown University, an MBA from Carleton University, and a PhD from the University of Cambridge, where he was a National Science Foundation Research Fellow.

Michael Rothman Co-Founder and Chief Science Officer

Michael Rothman, PhD

Co-Founder and Chief Science Officer
Michael Rothman Co-Founder and Chief Science Officer

We started PeraHealth to prevent another family from suffering from an avoidable death. But we also realized that we had discovered a way to actually view the physiology of disease progression and that this could be a tool to significantly accelerate medical research.

Michael Rothman, PhD

Co-Founder and Chief Science Officer

Michael Rothman co-founded PeraHealth in 2005 with his brother Steven, following the avoidable death of their mother, Florence.

His career began at IBM’s General Technology Division, after he earned his PhD in quantum chemistry. At IBM, he worked in optimization, mathematical modeling, and data analysis; work that led to a doubling of memory chip yields for mainframes. Michael also spent time at IBM’s T. J. Watson Research Labs, in the AI department, engaged in research in machine learning.

Michael is a natural interpreter of information. As a manager and executive consultant for the IBM Consulting group, his duties included translating mathematical results into effective business strategies for major banks and financial institutions. Later, as Senior Vice President for Strategic Information at First USA Bank, Michael established a database to better determine customer preferences.

In 2000, he founded Michael Rothman & Associates to focus on data analysis and product development through consulting, patent filing, and joint ventures. Projects have included developing a system generating customized discharge forms for hospitals, helping determine cash flow and profitability for a pharmaceutical company’s newly introduced drugs, and pro bono work analyzing mortality data for a guide dog school.

Michael earned an ScB and ScM in Chemistry from Brown University, and went on to earn a PhD in Chemistry from the University of Michigan.

Carolyn Minnock

Carolyn Minnock

Chief Growth Officer
Carolyn Minnock

I am continuously energized by the successes of our hospital partners utilizing the Rothman Index, and believe that we are only seeing the tip of the iceberg with regards to its potential. We have an exciting journey ahead!

Carolyn Minnock

Chief Growth Officer

Carolyn Minnock, PeraHealth's Chief Growth Officer, is passionate about improving healthcare through technology. Carolyn began her career working at Atrium Health as Director of their Area Health Education Center (AHEC). She then joined PeraHealth in 2015 and has taken on various roles – beginning as Director of Customer Engagement, to creating the Customer Success Team and serving as the company’s first Account Executive. She then utilized the many success stories from the customers she served to expand PeraHealth’s footprint in the provider space, while serving as Regional Vice President. In that role, her expertise in communicating the value the Rothman Index brings to organizations, knack for process management, and ability to develop channel partnerships shined. Carolyn is excited to continue to add to her experience with PeraHealth in this Senior Leadership role as she looks to redefine the vision for the future of the company.

Carolyn has a degree in Biology and MBA, focused on management, from John Carroll University. She enjoys spending time with her family and friends and traveling is one of her favorite things to do, especially to areas where she can learn from various cultures.

She hails from Pittsburgh where she is a true fan of their sports teams. Carolyn has spent the last 12 years in Charlotte where she resides with her wife, Brook and their two children Keegan and Connor, and loyal dog of 12 years, Bubba.

Tracee Karlsson, CPA

Vice President of Finance

It’s very fulfilling to come to work every day and collaborate with passionate professionals for a company that is dedicated to saving lives.

Tracee Karlsson, CPA

Vice President of Finance

Tracee joined PeraHealth as Controller in 2018 and is now the Vice President of Finance. She is responsible for the delivery of financial services such as accounting, reporting, budgeting, and forecasting. She has over 10 years of accounting and finance experience, most recently serving as Corporate Accounting Manager with Premier, Inc, a publicly held healthcare improvement company, dedicated to Supply Chain segments consisting of Direct Sourcing and Group Purchasing Services. Prior to Premier, Tracee was the Controller of a copay assistance program in the not-for-profit business unit at Lash Group, a subsidiary of AmerisourceBergen, also a publicly held company in the healthcare industry. She is passionate about helping to carry out a mission to improve lives and advance healthcare. Tracee is a CPA and graduated with a BBA in Information Systems from Georgia College & State University.

Bill Dorner

Vice President of Product Development

The application of machine learning and AI for healthcare clinical decision support can provide an enhanced level of care for patients. PeraHealth has been at the forefront of this with the introduction of the Rothman Index and I am excited to continue the evolution of our products to improve patient care.

Bill Dorner

Vice President of Product Development

With over 20 years of experience in software delivery and healthcare product management, Bill has a proven track record of delivering innovative product features. He has expertise in leading organizations through the rigorous development and quality processes of delivering safe and effective Software as a Medical Device (SaMD) while adhering to ISO 13485 standards. Prior to joining PeraHealth, he led the product management strategies for the healthcare-related products at Premier, Inc. and Monarch Medical Technologies, an FDA-regulated medical device company. In addition, Bill has worked in consulting, and with IBM delivering software products across many industries. Bill has degrees from Truman State University and Loyola Chicago University.

Michelle McCabe

Vice President, Client Engagement

I love working with our customers to utilize the Rothman Index to impact the care of their patients. To me—it’s the perfect blend of relationships, clinical engagement, and technology that helps us help our customers make a difference. It’s my privilege to be a part of this.

Michelle McCabe

Vice President, Client Engagement

Michelle joined PeraHealth in 2019 as Sr. Director of Customer Success and collaborates with clients to ensure they maximize value of The Rothman Index across their organization. She is focused on building strong partnerships with clients and supporting the strong adoption of PeraHealth solutions.

With over 20 years of experience working with health systems across the country, Michelle has an extensive background in healthcare information systems. Prior to PeraHealth, she spent more than a decade working with a leading evidence-based medicine solution, Zynx Health, in business development, relationship management, and leadership roles. She also worked for many years in customer relationship roles at Cerner Corporation.

Michelle holds a Bachelor of Arts degree in English from the University of South Florida in Tampa, FL.

Kathy Belk

SVP, Client Services and Strategic Analytics

I am excited to be a part of PeraHealth as my role brings together two things I am passionate about -- providing exemplary customer service and using data-driven insights to improve efficiency, safety, and quality in patient care.

Kathy Belk

SVP, Client Services and Strategic Analytics

Kathy is a health services researcher with more than 20 years of experience using healthcare data for clinical & economic research and performance improvement initiatives. ​She has extensive experience leading data-driven projects for hospitals as well as specialty societies and government agencies. Her work includes both traditional and innovative study designs across a wide range of topics and clinical areas and has resulted in more than 100 peer-reviewed publications and/or presentations in scientific journals and conferences. ​

Kathy has extensive data collection and linkage experience across many types of healthcare datasets including two used by the U.S. Food and Drug Administration, for which she was a subject matter expert.​ In a prior role with Premier, Inc., she served as data expert and lead scientist for an innovative pay-for-performance demonstration project with the Centers for Medicare & Medicaid Services. Kathy’s diverse background enables her to balance innovative strategy with rigorous scientific methodologies to create fit-for-purpose solutions.